These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 28714419)
1. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core. Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419 [TBL] [Abstract][Full Text] [Related]
2. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870 [TBL] [Abstract][Full Text] [Related]
3. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease. Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055 [TBL] [Abstract][Full Text] [Related]
4. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease. Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981 [TBL] [Abstract][Full Text] [Related]
5. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease. Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079 [TBL] [Abstract][Full Text] [Related]
6. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease. Yamali C; Donmez S Mini Rev Med Chem; 2023; 23(7):869-880. PubMed ID: 36464869 [TBL] [Abstract][Full Text] [Related]
7. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. Li Q; He S; Chen Y; Feng F; Qu W; Sun H Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151 [TBL] [Abstract][Full Text] [Related]
8. Multi-Target Drug Design of Anti-Alzheimer's Disease based on Tacrine. Tian S; Huang Z; Meng Q; Liu Z Mini Rev Med Chem; 2021; 21(15):2039-2064. PubMed ID: 33583371 [TBL] [Abstract][Full Text] [Related]
9. A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease. Sameem B; Saeedi M; Mahdavi M; Shafiee A Eur J Med Chem; 2017 Mar; 128():332-345. PubMed ID: 27876467 [TBL] [Abstract][Full Text] [Related]
10. Tacrine derivatives and Alzheimer's disease. Tumiatti V; Minarini A; Bolognesi ML; Milelli A; Rosini M; Melchiorre C Curr Med Chem; 2010; 17(17):1825-38. PubMed ID: 20345341 [TBL] [Abstract][Full Text] [Related]
11. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease. Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339 [TBL] [Abstract][Full Text] [Related]
12. ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker. Liu Z; Zhang B; Xia S; Fang L; Gou S Eur J Med Chem; 2021 Feb; 212():112997. PubMed ID: 33189440 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation. Remya C; Dileep KV; Koti Reddy E; Mantosh K; Lakshmi K; Sarah Jacob R; Sajith AM; Jayadevi Variyar E; Anwar S; Zhang KYJ; Sadasivan C; Omkumar RV Comput Struct Biotechnol J; 2021; 19():4517-4537. PubMed ID: 34471497 [TBL] [Abstract][Full Text] [Related]
14. The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease. Mesiti F; Chavarria D; Gaspar A; Alcaro S; Borges F Eur J Med Chem; 2019 Nov; 181():111572. PubMed ID: 31404859 [TBL] [Abstract][Full Text] [Related]
15. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update. de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563 [TBL] [Abstract][Full Text] [Related]
16. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines. Romero A; Marco-Contelles J Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586 [TBL] [Abstract][Full Text] [Related]
17. Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease. Rossi M; Freschi M; de Camargo Nascente L; Salerno A; de Melo Viana Teixeira S; Nachon F; Chantegreil F; Soukup O; Prchal L; Malaguti M; Bergamini C; Bartolini M; Angeloni C; Hrelia S; Soares Romeiro LA; Bolognesi ML J Med Chem; 2021 Apr; 64(8):4972-4990. PubMed ID: 33829779 [TBL] [Abstract][Full Text] [Related]
18. New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines. Oset-Gasque MJ; Marco-Contelles J Curr Top Med Chem; 2017; 17(31):3349-3360. PubMed ID: 29332585 [TBL] [Abstract][Full Text] [Related]
19. Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research. Jankowska A; Wesolowska A; Pawlowski M; Chlon-Rzepa G Curr Med Chem; 2018; 25(17):2045-2067. PubMed ID: 28554324 [TBL] [Abstract][Full Text] [Related]
20. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents. George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]